Skip to content

Clinical trials

Dyslipidemias trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Norway Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20042
20052
20062
20121
20131
20143
20161
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowa Research Europe3
Amgen2
Sanofi2
Takeda2
Apokus AS1
Genentech, Inc.1
GlaxoSmithKline1
Haukeland University Hospital1
NewAmsterdam Pharma1
Norwegian University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias17
Hypercholesterolemia8
Diabetes Mellitus, Type 24
Hypertension3
Cardiovascular Diseases2
Diabetes Mellitus2
Glucose Metabolism Disorders2
Hyperlipidemias2
Atherosclerosis1
Coronary Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.